Skip to main content
Eye logoLink to Eye
letter
. 2020 Aug 10;35(7):2064–2066. doi: 10.1038/s41433-020-01130-4

Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK

Darren Shu Jeng Ting 1,, Sherine Krause 2, Dalia G Said 1, Harminder S Dua 1,
PMCID: PMC7417103  PMID: 32778740

To the Editor:

In response to the Coronavirus disease 2019 (or COVID-19) pandemic, many countries across the world, including the UK, had imposed nationwide lockdown. Ophthalmology represents one of the busiest outpatient-based specialties, and cancellation of routine services meant that thousands of eye patients had been affected. Several studies have previously shown that COVID-19 lockdown and quarantine in general could negatively impact on the mental health of adults, children, and healthcare workers [13], but the impact of people with eye diseases has not been evaluated. In this survey, we aimed to evaluate the psychosocial impact of COVID-19 lockdown on people living with eye diseases in the UK.

In May 2020, a 27-item online questionnaire-based survey was administered to individuals (≥18 years old) with eye diseases (Supplementary Table 1). Participants were identified through various eye support charities or support groups. The level of visual impairment (VI) was categorised into normal/mild, moderate, and severely sight impaired/blind. Statistical analysis was performed using IBM SPSS Statistics v26. Multivariable logistic regression analysis was conducted to determine the predictive factors for worsened mental health, loneliness, and fear of further sight loss during lockdown. Ethical approval of this survey was waived as no medical assessment/intervention was performed. Informed consent for publication was obtained from all participants.

Of all 325 respondents, 64.3% were ≥65 years and 71.1% were female (Supplementary Table 2). The level of VI was none/mild (34.8%), moderate (38.2%), severe/blind (24.9%), and unmentioned (8.3%). The lockdown negatively impacted on the mental health (45.9%), loneliness (46.0%), social life (85.3%), anxiety related to hospital visits (55.1%), and fear of further sight loss due to delayed review/treatment (45.9%), amongst others (Fig. 1). In addition, 39.2% respondents mentioned that their eye diseases had made it more difficult to cope with the lockdown. Logistic regression analyses demonstrated that the lockdown had significantly affected the mental health of people who were of 18–64 years (OR 3.16; p < 0.001), and with moderate (OR 2.61; p = 0.001) or severe VI (OR 2.07; p = 0.044; Table 1). People with moderate or severe VI were three times more likely to experience increased loneliness than those with mild/no VI (p < 0.001 and p = 0.002, respectively). Fear of further sight loss was similar across all age groups, gender, and extent of VI (all p > 0.05). The open comments reflected anxiety, stress, and fear impacting on mental health, compounded by the limitations posed by their VI on undertaking routine activities or providing care to other family members.

Fig. 1. Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases.

Fig. 1

The questions (Q) asked in each column corresponds with the question number listed in the questionnaire (see Supplementary Table 1). “Strongly agree/agree” means that the respondents agreed that the lockdown had a negative impact on the questioned aspect and vice versa for “strongly disagree/disagree”.

Table 1.

Multivariable logistic regression analyses examining the predictive factors for worsened mental health, loneliness, and fear of further sight loss in people living with eye diseases during the COVID-19 pandemic lockdown.

Mental health
OR (95% CI)
P value Loneliness
OR (95% CI)
P value Fear of sight loss
OR (95% CI)
P value
Age, years
 18–64 3.16 (1.81–5.52) <0.001 1.30 (0.76–2.23) 0.35 1.00 (0.50–1.99) >0.99
 65 or older Reference Reference Reference
Gender
 Male Reference Reference Reference
 Female 1.44 (0.80–2.59) 0.23 1.60 (0.88–2.91) 0.12 0.91 (0.43–1.94) 0.81
Ethnicity
 White Reference Reference Reference
 BAME 0.34 (0.07–1.61) 0.18 0.96 (0.23–3.99) 0.96 1.03 (0.17–6.07) 0.98
Extent of sight loss
 Mild or no VI Reference Reference Reference
 Moderate VI 2.61 (1.45–4.70) 0.001 2.99 (1.69–5.32) <0.001 1.10 (0.54–2.26) 0.79
 Severe VI or blind 2.07 (1.02–4.19) 0.044 3.02 (1.51–6.07) 0.002 1.28 (0.51–3.22) 0.60

Statistically significant values are underlined.

OR odd ratio, CI confidence interval, BAME Black, Asian and minority ethnicity, VI visual impairment.

Sight loss is a big health concern, and delay in follow-up and care could result in significant and/or permanent harm to vision [4]. We highlighted that COVID-19 lockdown could pose a significant negative psychosocial impact on people with VI. It is therefore important to recognise and provide additional psychosocial support to this vulnerable group of people during the pandemic [3].

COVID-19 pandemic has posed challenges but also presented new opportunities. In view of the significant backlog of work and ongoing social distancing measures, adoption of telemedicine in ophthalmology will likely become the new “norm” of ophthalmology during and after the pandemic [5].

Supplementary information

Supplementary Table 1 (15.9KB, docx)
Supplementary Table 2 (15.7KB, docx)

Funding

DSJT acknowledges support from the Medical Research Council/Fight for Sight Clinical Research Fellowship (MR/T001674/1) and the Fight for Sight/John Lee, Royal College of Ophthalmologists Primer Fellowship (24CO4).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Darren Shu Jeng Ting, Email: ting.darren@gmail.com.

Harminder S. Dua, Email: profdua@gmail.com

Supplementary information

The online version of this article (10.1038/s41433-020-01130-4) contains supplementary material, which is available to authorized users.

References

  • 1.McGinty EE, Presskreischer R, Han H, Barry CL. Psychological distress and loneliness reported by US adults in 2018 and April 2020. JAMA. 2020;324:e209740. doi: 10.1001/jama.2020.9740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–20. doi: 10.1016/S0140-6736(20)30460-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Razai MS, Oakeshott P, Kankam H, Galea S, Stokes-Lampard H. Mitigating the psychological effects of social isolation during the covid-19 pandemic. BMJ. 2020;369:m1904. doi: 10.1136/bmj.m1904. [DOI] [PubMed] [Google Scholar]
  • 4.Foot B, MacEwen C. Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome. Eye. 2017;31:771–5. doi: 10.1038/eye.2017.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ting DSJ, Foo VH, Yang LWY, Sia JT, Ang M, Lin H, et al. Artificial intelligence for anterior segment diseases: emerging applications in ophthalmology. Br J Ophthalmol. 2020 doi: 10.1136/bjophthalmol-2019-315651. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table 1 (15.9KB, docx)
Supplementary Table 2 (15.7KB, docx)

Articles from Eye are provided here courtesy of Nature Publishing Group

RESOURCES